These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15712733)

  • 21. [Prevention of thrombosis in hip alloplasty].
    Borris LC; Petersen MB; Lassen MR
    Ugeskr Laeger; 2001 Feb; 163(7):934; discussion 934-5. PubMed ID: 11228793
    [No Abstract]   [Full Text] [Related]  

  • 22. [Standard prevention of thrombosis in hip and knee alloplasties].
    Thomsen PB
    Ugeskr Laeger; 2001 Feb; 163(7):937-8. PubMed ID: 11228795
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery.
    Heit JA
    Arch Intern Med; 2002 Sep; 162(16):1806-8. PubMed ID: 12196077
    [No Abstract]   [Full Text] [Related]  

  • 25. The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study.
    Singelyn FJ; Verheyen CC; Piovella F; Van Aken HK; Rosencher N;
    Anesth Analg; 2007 Dec; 105(6):1540-7, table of contents. PubMed ID: 18042845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG
    J Thromb Haemost; 2003 Feb; 1(2):383-4. PubMed ID: 12871516
    [No Abstract]   [Full Text] [Related]  

  • 28. Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
    Kawaji H; Ishii M; Tamaki Y; Hamasaki M; Ishikawa H; Sasaki K; Dairaku K; Takagi M
    Mod Rheumatol; 2012 Apr; 22(2):216-22. PubMed ID: 21761228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of venous thromboembolism: the seventh conference American College of Chest Physician (ACCP)].
    Trc T; Kvasnicka J; Kudrnová Z
    Acta Chir Orthop Traumatol Cech; 2007 Apr; 74(2):126-31. PubMed ID: 17493415
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of venous thromboembolism in patients.
    Hairon N
    Nurs Times; 2007 May 1-7; 103(18):23-4. PubMed ID: 17508658
    [No Abstract]   [Full Text] [Related]  

  • 31. Fondaparinux versus enoxaparin for prevention of venous.
    Morris E
    Lancet; 2002 Nov; 360(9345):1604-5; author reply 1605. PubMed ID: 12443628
    [No Abstract]   [Full Text] [Related]  

  • 32. [Deficient thrombosis prophylaxis].
    Holme PA
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1176. PubMed ID: 17479132
    [No Abstract]   [Full Text] [Related]  

  • 33. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
    Bauersachs R; Alban S
    Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522
    [No Abstract]   [Full Text] [Related]  

  • 34. Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol.
    Beksaç B; González Della Valle A; Anderson J; Sharrock NE; Sculco TP; Salvato EA
    Clin Orthop Relat Res; 2007 Oct; 463():114-9. PubMed ID: 17960674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolism--an academic concern or a clinical reality?
    Dahl OE; Frostick SP; Hull RD
    Acta Orthop Scand; 1999 Aug; 70(4):404-6. PubMed ID: 10569277
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement.
    Kearon C; Comp P; Douketis J; Royds R; Yamada K; Gent M
    J Thromb Haemost; 2005 May; 3(5):962-8. PubMed ID: 15869592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perioperative thrombosis prophylaxis--where are we going?].
    Jørgensen LN; Wille-Jørgensen P
    Ugeskr Laeger; 2005 May; 167(21):2259. PubMed ID: 15962849
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention and treatment of venous thromboses and thromboembolism: pentasaccharides as novel anticoagulants selectively blocking Xe factor, their position and potential (data of the XIX International Congress on Thromboses and Hemostasis)].
    Averkov OV
    Angiol Sosud Khir; 2004; 10(3):12-23. PubMed ID: 15622389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based guidelines for venous thromboembolism prophylaxis in orthopedic surgery.
    Colwell CW
    Orthopedics; 2007 Feb; 30(2):129-35; quiz 136-7. PubMed ID: 17323635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.